Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - metaraminol tartrate, quantity: 5.7 mg - injection - excipient ingredients: sodium chloride; sodium metabisulfite; water for injections; sodium hydroxide; tartaric acid - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma.,it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - metaraminol tartrate, quantity: 9.5 mg - injection - excipient ingredients: sodium chloride; water for injections; sodium metabisulfite; sodium hydroxide; tartaric acid - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma.,it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - metaraminol tartrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - metaraminol tartrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - metaraminol tartrate, quantity: 19 mg (equivalent: metaraminol, qty 10 mg) - injection, solution - excipient ingredients: glacial acetic acid; sodium acetate trihydrate; disodium edetate; citric acid monohydrate; water for injections; sodium chloride - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma.,it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

wockhardt bio pty ltd - metaraminol tartrate, quantity: 19 mg - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium metabisulfite; sodium hydroxide - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

wockhardt bio pty ltd - metaraminol tartrate, quantity: 9.5 mg - injection, solution - excipient ingredients: sodium metabisulfite; sodium hydroxide; water for injections; hydrochloric acid; sodium chloride - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

wockhardt bio pty ltd - metaraminol tartrate, quantity: 19 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; sodium metabisulfite; sodium chloride; hydrochloric acid - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

wockhardt bio pty ltd - metaraminol tartrate, quantity: 9.5 mg - injection, solution - excipient ingredients: water for injections; sodium hydroxide; sodium chloride; sodium metabisulfite; hydrochloric acid - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - metaraminol tartrate, quantity: 18.96 mg (equivalent: metaraminol, qty 10 mg) - injection - excipient ingredients: water for injections; sodium metabisulfite; sodium chloride; sodium hydroxide; tartaric acid - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma.,it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.